Condition
Febrile Neutropenia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Febrile Neutropenia clinical trials that are recruiting, at sites in 5 countries (most in China (1), Brazil (1), Germany (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Febrile Neutropenia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Plasma Host-Microbe Proteomics to Predict Complications in High-Risk Febrile Neutropenia | — | Barcelona, Barcelona and 2 other locations | Recruiting | Dec 11, 2025 |
| Stepwise antibiotic and antifungal treatment for febrile neutropenia in blood cancer patients | — | Taiyuan, Shanxi | Recruiting | Oct 2, 2025 |
| Comparing Ceftolozane/Tazobactam and Meropenem for Febrile Neutropenia in Patients at Risk for ESBL Infections | Phase 4 | São Paulo | Recruiting | Apr 2, 2024 |
| Adjusting antibiotic doses for children with cancer and infections | Phase 4 | Lausanne, Canton of Vaud | Recruiting | Mar 5, 2024 |
| Using next-generation sequencing to detect infections in neutropenic patients with fever | — | Cologne and 5 other locations | Recruiting | Apr 18, 2023 |
All recruiting trials (5)
-
Plasma Host-Microbe Proteomics to Predict Complications in High-Risk Febrile Neutropenia
Researchers will test a combined host and microbial blood proteome to see if it can predict which high-risk febrile neutropenia patients will develop complications.
-
Stepwise antibiotic and antifungal treatment for febrile neutropenia in blood cancer patients
This treatment plan tests whether a stepwise escalation of antibiotics and antifungals can control infection and fever in adults with hematologic malignancies who develop febrile neutropenia.
-
Comparing Ceftolozane/Tazobactam and Meropenem for Febrile Neutropenia in Patients at Risk for ESBL Infections
This study is testing if a new antibiotic called Ceftolozane/Tazobactam works just as well as Meropenem for people with febrile neutropenia who are at risk for certain infections.
-
Adjusting antibiotic doses for children with cancer and infections
This study is testing how to adjust antibiotic doses for children with cancer who have infections to make sure they get the right amount of medicine when their kidneys clear it from their bodies too quickly.
-
Using next-generation sequencing to detect infections in neutropenic patients with fever
This study is testing a new method using advanced DNA technology to see if it can help doctors quickly find infections in patients with low white blood cell counts and fever.
Quick answers
How many Febrile Neutropenia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (1 trial), Brazil (1 trial), Germany (1 trial), Spain (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.